Evidence map›Paper›PMID 27599722›Full record

ArticleJournal of experimental & clinical cancer research : CR2016

Reactivation of mutant p53 by capsaicin, the major constituent of peppers.

Alessia Garufi, Giuseppa Pistritto, Mara Cirone, Gabriella D'Orazi

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Hydroxychavicol, a polyphenol fromJournal of Zhejiang University. Science. B · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Alessia GarufiRegina Elena National Cancer Institute, Department of Research, Advanced Diagnostics, and Technological Innovation, Unit of Cellular Networks and Molecular Therapeutic Targets, Rome, 00144, Italy.
Giuseppa PistrittoDepartment of Systems Medicine, University "Tor Vergata", Rome, 00133, Italy.
Mara CironeDepartment of Experimental Medicine, Istituto Pasteur Fondazione Cenci Bolognetti, University "Sapienza", Rome, 00161, Italy.
Gabriella D'OraziRegina Elena National Cancer Institute, Department of Research, Advanced Diagnostics, and Technological Innovation, Unit of Cellular Networks and Molecular Therapeutic Targets, Rome, 00144, Italy. gabriella.dorazi@unich.it.
University of Chieti-Pescara · ITIstituto Pasteur · ITUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMutations in the p53 oncosuppressor gene are highly frequent in human cancers. These alterations are mainly point mutations in the DNA binding domain of p53 and disable p53 from transactivating target genes devoted to anticancer activity. Mutant p53 proteins are usually more stable than wild-type p53 and may not only impair wild-type p53 activity but also acquire pro-oncogenic functions. Therefore, targeting mutant p53 to clear the hyperstable proteins or change p53 conformation to reactivate wild-type p53 protein functions is a powerful anticancer strategy. Several small molecules have been tested for p53 reactivation in mutant p53-carrying cells while studies exploiting the effect of natural compounds are limited. Capsaicin (CPS) is the major constituent of peppers and show antitumor activity by targeting several molecular pathway, however, its effect on mutant p53 reactivation has not been assessed yet. In this study we aimed at investigating whether mutant p53 could be a new target of capsaicin-induced cell death and the underlying mechanisms.

methodsp53 levels were analysed by western blot upon capsaicin treatment in the presence of the autophagy inhibitor chloroquine. The mutant p53 reactivation was evaluated by chromatin-immunoprecipitation (ChIP) assay and semi-quantitative RT-PCR analyses of wild-type p53 target genes. The specific wild-type p53 activation was determined by using the inhibitor of p53 transactivation function, pifithrin-α and siRNA for p53.

resultsHere, we show that capsaicin induced autophagy that was, at least in part, responsible of mutant p53 protein degradation. Abrogation of mutant p53 by capsaicin restored wild-type p53 activities over mutant p53 functions, contributing to cancer cell death. Similar effects were confirmed in cancer cells bearing tumor-associated p53 mutations and in H1299 (p53 null) with overexpressed p53R175H and p53R273H mutant proteins.

conclusionThese findings demonstrate for the first time that capsaicin may reduce mutant p53 levels and reactivate wild-type p53 protein in mutant p53-carrying cells and the p53 reactivation contributes to capsaicin-induced cell death.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicApoptosisCapsaicinCapsicumCell Line, TumorCell ProliferationCell SurvivalChloroquineGene Expression Regulation, NeoplasticHumansMiceMutationNeoplasmsProteolysisSignal TransductionAntineoplastic Agents, PhytogenicCapsaicinChloroquineTP53 protein, humanTumor Suppressor Protein p53ApoptosisAutophagyCapsaicinMutant p53Natural compoundsp53p53 reactivation

Identifiers

PMID27599722
PMCPMC5012067
OpenAlexW2512500289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.